Clinical Trials at Stanford University
As of September 2026, 119 paid clinical trials are recruiting at Stanford University, located at 875 BLAKE WILBUR DRIVE, STANFORD, CA 94305-5847, phone (650) 723-6171 in Stanford, California. Active studies at this site cover conditions such as Autism Spectrum Disorder, Autism and Atrial Fibrillation. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Stanford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
120 clinical trials at Stanford University
·Clear filters·Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
DALY II USA/ MB-CART2019.1 for DLBCL
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
AI-driven Total Parenteral Nutrition Platform
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Body Clocks - Coordination of Peripheral and Central Oscillators
A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants
Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
Sit Less, Interact and Move More (SLIMM) 2 Study
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Oxytocin Pharmacokinetics and Pharmacodynamics
Measuring Surgical Recovery After Radical Cystectomy
Common conditions studied in Stanford
- Autism Spectrum Disorder (17 active studies)
- Autism (12 active studies)
- Atrial Fibrillation (7 active studies)
- Breast Cancer (7 active studies)
- Cancer (7 active studies)
- Heart Failure (6 active studies)
Leading research sponsors in Stanford
- Stanford University
- Eli Lilly and Company
- AstraZeneca
- Memorial Sloan Kettering Cancer Center
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Stanford?
There are approximately 426 recruiting clinical trials in Stanford, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stanford pay participants?
Most recruiting trials in Stanford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stanford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stanford?
The most common conditions under active study in Stanford include Autism Spectrum Disorder (17), Autism (12), Atrial Fibrillation (7), Breast Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stanford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stanford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stanford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stanford?
Recruiting research sites in Stanford include Stanford University, Stanford University School of Medicine, Stanford University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stanford right now?
The largest active categories in Stanford are Cancer & tumors (84), Cardiovascular (43), Neurology & pain (37). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Stanford University?
Stanford University is located at 875 BLAKE WILBUR DRIVE, STANFORD, CA 94305-5847. Use the Google Maps link in the intro above to get directions.
How do I contact Stanford University?
You can reach Stanford University by phone at (650) 723-6171. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.